Article info
PDFSystematic review
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations
- Correspondence to Kevin J Frost, Airedale NHS Foundation Trust, Keighley BD20 6TD, UK; kevin.frost{at}nhs.net
Citation
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations
Publication history
- Received June 10, 2022
- Accepted October 17, 2022
- First published November 7, 2022.
Online issue publication
June 23, 2023
Article Versions
- Previous version (23 June 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.